Scott E. Ludwig

American College of LLC and Partnership Attorneys, Founding Fellow; President American College of Tax Counsel, Fellow American Bar Association LLCs, Partnerships and Unincorporated Entities Committee’s Martin I. Lubaroff Award, 2016 Business Law Section Chair's Award Recipient, 2010 Listed in The Best Lawyers in America® Biotechnology and Life Sciences Practice, 2007-2025 Corporate, M&A, and Securities Law, 1999-2006 Corporate Law, 2006-2025 Litigation and Controversy – Tax, 2011-2025 Litigation – Trusts & Estates, 2011-2025 Non-Profit/Charities Law, 2007-2025 Tax Law, 1995-2025 Trusts and Estates, 2003-2025 Business Organizations [including LLCs and Partnerships], 2024-2025 American Bar Foundation, Fellow Alabama Law Institute, Elected Member Listed in Mid-South Super Lawyers, Business/Corporate, 2016-2021 Listed in Alabama Super Lawyers, Business/Corporate, 2012-2015 Listed in Who's Who in American Law HudsonAlpha Institute for Biotechnology Provide legal advice for the establishment and operation of HudsonAlpha Institute for Biotechnology, HudsonAlpha Foundation, and their respective subsidiaries. The Institute focuses on genomic research, personalized genomic health, education, and economic development. The Institute is home to the world’s first Medical Genomics Clinic. Since its inception, the Institute has generated more than $2.45 billion in economic impact. Recently advised the Institute on a venture combining the Genomics Services Lab with Discovery Life Sciences, LLC, for an undisclosed amount, and assisted in the establishment of HudsonAlpha Health Alliance LLC. Additionally, provide advice on state inducement arrangements and other incentive programs/structures. Serina Therapeutics, Inc. Provided legal advice for the establishment and operation of Serina since its inception. Advised Serina in raising over $40 million in various capital rounds, establishing stock option plans and other incentive programs, and various corporate governance and tax matters. Represented Serina in connection with one of the largest known cannabidiol licensing transactions for an undisclosed amount. Represented Serina in connection with its reverse merger with AgeX, Inc. (NYSE American: AGE), now listed as Serina Therapeutics, Inc. (NYSE American: SER). Kailos Genetics, Inc/BioHSV Holdings, Inc. Represented Kailos and BioHSV since their inception. Advised in raising over $20 million in various rounds of equity and debt structures. Assisted with various lab agreements, FDA compliance issues, and HIPAA issues. Provide general corporate advice regarding corporate structure, corporate governance, contract issues, stock option plans, stock incentive plans, and other corporate matters. Haysland Farms Group Represent developer of large-scale commercial, residential, and mixed-use developments, including advising client on interaction with local governments, contract advice, and other corporate governance, tax, and structural advice. Indorama Provide advice to Indorama regarding tax matters, acquisition of the BP Decatur site for an undisclosed amount, construction matters, and other related matters.  Rex Companies Represent developer of large-scale commercial, residential, and mixed-use developments, including advising client on contract advice, and other corporate governance, tax, and structural advice. Valley Pizza, Inc. Represented Valley Pizza in the sale of Alabama and Tennessee Dominos Pizza stores and associated real estate for an undisclosed amount. Tim Whitehead Chrysler, Inc. Represented the company in the sale of its dealership and the lease of its real property for an undisclosed amount. EGEN Represented EGEN, Inc. in connection with its sale to Celsion Corporation (Nasdaq: CLSN) for $44 million. EGEN developed nucleic acid-based therapeutics for the treatment of cancer and other diseases. Open Biosystems, Inc. Represented Open Biosystems in connection with its sale to Thermo Fisher Scientific Inc. (NYSE: TMO) for $47.5 million. Open Biosystems was a provider of RNA interference (RNAi), gene expression, and protein detection products for life science research and drug discovery. Shearwater Polymers, Inc. Represented Shearwater Polymers, Inc. in connection with its sale to Nektar Therapeutics (Nasdaq: NKTR) for $191 million. Shearwater developed a unique drug delivery process using PEG polymer technology. Nektar Local counsel to Nektar Therapeutics in issuance of $315 million convertible debt. Goodyear Local counsel to Goodyear Dunlop Tires North America, Ltd. in the acquisition of Dunlop Tires Corporation’s assets for $1 billion.